186 related articles for article (PubMed ID: 18372441)
1. Oral anticoagulants and non-cardioembolic stroke prevention.
Schachter ME; Tran HA; Anand SS
Vasc Med; 2008 Feb; 13(1):55-62. PubMed ID: 18372441
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet and anticoagulation strategies in the prevention and treatment of ischemic stroke.
Kirshner HS
Curr Pharm Des; 2012; 18(33):5261-72. PubMed ID: 22724413
[TBL] [Abstract][Full Text] [Related]
3. Filling the gap between science & clinical practice: prevention of stroke recurrence.
Russolillo A; Di Minno MN; Tufano A; Prisco D; Di Minno G
Thromb Res; 2012 Jan; 129(1):3-8. PubMed ID: 21907395
[TBL] [Abstract][Full Text] [Related]
4. [Update on antithrombotic secondary prevention of ischemic stroke].
Köhrmann M; Kleinschnitz C
Nervenarzt; 2019 Oct; 90(10):995-1004. PubMed ID: 31560112
[TBL] [Abstract][Full Text] [Related]
5. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
Wang Y; Chen W; Wang Y
Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
7. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischemic attack or minor stroke of presumed arterial origin.
Algra A; De Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Stroke; 2003 Jan; 34(1):234-5. PubMed ID: 12511782
[No Abstract] [Full Text] [Related]
8. [Antiplatelet treatment for secondary prevention of ischemic stroke or transient ischemic attack].
Barinagarrementeria F; Arauz A; Ruiz-Sandoval JL; Cantú C; Leyva A; Murillo L; Villarreal J; Vargas RD; Alegría MA; Merino JG; Romano J;
Rev Invest Clin; 2010; 62(2):135-40. PubMed ID: 20597393
[No Abstract] [Full Text] [Related]
9. Antiplatelet agents in stroke prevention: acute and long-term treatment strategies.
Weber R; Weimar C; Diener HC
Hamostaseologie; 2009 Nov; 29(4):326-33. PubMed ID: 19882077
[TBL] [Abstract][Full Text] [Related]
10. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
Davis SM; Donnan GA
N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
[No Abstract] [Full Text] [Related]
11. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack.
Depta JP; Fowler J; Novak E; Katzan I; Bakdash S; Kottke-Marchant K; Bhatt DL
Stroke; 2012 Sep; 43(9):2376-81. PubMed ID: 22713488
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
Aw D; Sharma JC
Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
[TBL] [Abstract][Full Text] [Related]
13. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
Weber R; Weimar C; Diener HC
Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
[TBL] [Abstract][Full Text] [Related]
14. Stroke subtypes and interventional studies for transient ischemic attack.
Lavallée P; Amarenco P
Front Neurol Neurosci; 2014; 33():135-46. PubMed ID: 24157562
[TBL] [Abstract][Full Text] [Related]
15. Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke.
Shrestha S; Coy S; Bekelis K
Curr Pharm Des; 2017; 23(9):1377-1391. PubMed ID: 28003013
[TBL] [Abstract][Full Text] [Related]
16. Role of Antiplatelet Therapy in Stroke Prevention in Patients With Atrial Fibrillation.
Manaktala R; Kluger J
J Am Osteopath Assoc; 2017 Dec; 117(12):761-771. PubMed ID: 29181519
[TBL] [Abstract][Full Text] [Related]
17. Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.
Kaplan ED; Sacco RL
Curr Neurol Neurosci Rep; 2002 Jan; 2(1):31-7. PubMed ID: 11898580
[TBL] [Abstract][Full Text] [Related]
18. Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
Riaz H; Alansari SA; Khan MS; Riaz T; Raza S; Luni FK; Khan AR; Riaz IB; Krasuski RA
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):294-302. PubMed ID: 27166205
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
[TBL] [Abstract][Full Text] [Related]
20. Network meta-analysis of antiplatelet treatments for secondary stroke prevention.
Baumgartner RW
Eur Heart J; 2008 May; 29(9):1082-3. PubMed ID: 18359758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
